Granules India Limited Metformin Export Data — India (DGFT 2022–2026)

Name: Granules India Limited Metformin Export Records India — #1 Exporter, 2,278 Shipments, $113.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Metformin

India Pharmaceutical Trade Intelligence

$466.4M528 Suppliers160 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → GEORGIA9.7%

ImportsGREECE → India$37.7B GERMANY → India$15.6M

#1 Supplier: GRANULES INDIA

Granules India Limited — Metformin Exporter #1 | $113.9M Trade Value | TransData Nexus | TransData Nexus

Granules India Limited — Metformin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Metformin · $113.9M export value · DGFT Verified

Granules India Limited is the #1 Indian exporter of Metformin with $113.9M in export value and 2,278 verified shipments. Granules India Limited holds a 24.4% market share in Metformin exports across 19 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.

Granules India Limited — Metformin Export Profile: Buyers & Destinations

Granules India Limited Metformin export treemap — buyers and destination countries | TransData Nexus

Where Does Granules India Limited Export Metformin?

Country	Value	Shipments	Share
UNITED STATES	$98.8M	2,728	66.4%
FRANCE	$12.6M	392	8.5%
CANADA	$5.3M	130	3.6%
NETHERLANDS	$5.0M	161	3.4%

Who Are the Top Buyers of Metformin from Granules India Limited?

Buyer	Country	Value	Orders
GRANULES PHARMACEUTICALS, INC.	UNITED STATES	$35.6M	971
GRANULES PHARMACEUTICALS INC	UNITED STATES	$28.1M	726
GRANULES PHARMACEUTICALS, INC	UNITED STATES	$22.4M	746
CSP VIATRIS SANTE AT CSP- LAB	FRANCE	$5.3M	201
MYLAN PHARMACEUTICALS INC	UNITED STATES	$5.2M	109
ASCEND LABORATORIES LLC	UNITED STATES	$4.2M	97
MANX HEALTHCARE	UNITED KINGDOM	$3.3M	168
SAG MANUFACTURING SLU	SPAIN	$3.2M	66
PRIORITY HEALTHCARE DISTRIBUTION	UNITED STATES	$2.9M	68
CSP MYLAN SAS AT CSP-LABO 274	FRANCE	$2.7M	65

Granules India Limited supplies Metformin to 102 buyers globally. The largest buyer is GRANULES PHARMACEUTICALS, INC. (UNITED STATES), followed by GRANULES PHARMACEUTICALS INC (UNITED STATES) and GRANULES PHARMACEUTICALS, INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Metformin Formulations Does Granules India Limited Export?

Product Description / Formulation	Value	Shipments
METFORMIN HYDROCHLORIDE TABLETS USP 1000	$8.6M	198
METFORMIN HYDROCHLORIDE TABLETS USP 500M	$5.5M	136
METFORMIN HCL EXTENDED-RELEASE TABLETS,	$3.4M	72
METFORMIN TABLETS 850 MG (GALENICUM - SA	$2.5M	49
Metformin HCl BB 500mg T 500s Metformin	$2.1M	42
METFORMIN HYDROCHLORIDE 500MG FILM-COTED	$1.3M	60
METFORMIN HCL EXTENDED RELEASE TABLETS,	$1.3M	25
METFORMIN HCL EXTENDED-RELEASE TABLETS	$1.2M	24
METFORMIN HYDROCHLORIDE EXTENDED RELEASE	$1.1M	42
METFORMIN HYDROCHLORIDE 850MG FILM-COATE	$869.2K	36

Granules India Limited exports 1897 distinct Metformin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METFORMIN HYDROCHLORIDE TABLETS USP 1000 with 198 shipments worth $8.6M.

How Does Granules India Limited Compare to Nearest Metformin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GRANULES INDIA LIMITED ★	$113.9M	2,278	19	$50.0K
5	ZENTIVA PRIVATE LIMITED	$19.4M	585	5	$33.2K
4	IPCA LABORATORIES LIMITED	$17.1M	342	14	$50.0K

Granules India Limited ranks #1 among 528 Indian Metformin exporters. Average shipment value of $50.0K compared to the market average of $504.7K. The closest competitors by value are ZENTIVA PRIVATE LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Metformin Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	2,284	15.2%
SAHAR AIR CARGO ACC (INBOM4)	1,638	10.9%
HYDERABAD ICD (INSNF6)	1,593	10.6%
DELHI AIR CARGO ACC (INDEL4)	1,355	9.0%
SAHAR AIR	1,015	6.8%
JNPT/ NHAVA SHEVA SEA	843	5.6%
DELHI AIR	711	4.7%
Bombay Air	695	4.6%

Geopolitical & Trade Policy Impact on Granules India Limited's Metformin Exports

Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)

The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.

Granules India Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)

Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Metformin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 4,305 individual customs records matching Granules India Limited exporting Metformin, covering 1897 formulations to 24 countries via 102 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 160+ countries, 1,475+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Metformin

Metformin

Granules India Limited — Metformin Exporter Profile

Granules India Limited — Metformin Export Profile: Buyers & Destinations

Where Does Granules India Limited Export Metformin?

Who Are the Top Buyers of Metformin from Granules India Limited?

What Is India's Total Metformin Export Value and How Much Does Granules India Limited Contribute?

What Is the Average Shipment Value for Granules India Limited's Metformin Exports?

How Does Granules India Limited Compare to Other Indian Metformin Exporters?

What Metformin Formulations Does Granules India Limited Export?

Regulatory Requirements: Exporting Metformin to Key Markets

United States — FDA

Canada — HC

How Does Granules India Limited Compare to Nearest Metformin Exporters?

Which Indian Ports Ship Metformin Exports?

Metformin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Granules India Limited's Metformin Exports

Granules India Limited — Regulatory Compliance & Quality Standards

About Granules India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Metformin Export Data from Granules India Limited

Metformin Stats

Company Overview

Top Products by Granules India Limited

Related Analysis

Need Detailed Export Data?

Data Source